Ovata Capital Management’s Lunai Bioworks LNAI Stock Holding History

Ovata Capital Management’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4	Closed	-$2K	–	124
2022 Q1	$2K	Buy	+4	New	+$2.13K	﹤0.01%	186

Other funds holding LNAI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Ovata Capital Management's LNAI Position: Q2 2022 in Review

Ovata Capital Management sold out of Lunai Bioworks (LNAI) in Q2 2022, closing a stake of 4 shares — an estimated $2K sold.

Ovata Capital Management first reported a position in LNAI in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 51 funds tracked by Wall St. Rank hold LNAI as of Q2 2022.

Ovata Capital Management reported no remaining Lunai Bioworks position as of Q2 2022 after selling out during the quarter.
Ovata Capital Management sold 4 Lunai Bioworks shares in Q2 2022, an estimated $2K.
Ovata Capital Management first reported a position in Lunai Bioworks in Q1 2022 and held it in 1 quarter.
Ovata Capital Management's Lunai Bioworks position peaked at $2K in Q1 2022.
51 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2022.

Based on Ovata Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.